Pfizer, Moderna, and Johnson & Johnson (J&J) committed to supply a total of 240 million doses to the US government by the end of March, with 220 million coming from Pfizer and Moderna and an additional 20 million from J&J (pending receipt of an EUA). Manufacturing these new vaccines at such a large scale is posing challenges, including in obtaining raw materials and optimizing manufacturing processes, but Pfizer and Moderna are working to increase supply. As vaccine supply increases, the CDC is increasing support for the general public to accelerate vaccine administration. This week, the CDC unveiled the VaccineFinder.org website, which provides US residents with updated information regarding local vaccine availability, including locations of local pharmacies, clinics, and health departments with available doses. For locations with vaccine in stock, individuals can also check appointment availability. The website is managed collaboratively by the CDC, Boston Children’s Hospital, Harvard Medical School, and Castlight. Initially, the website included data on 29,000 locations nationwide, but it is expected to expand. We now can provide vaccine to individuals under 65 with three or more “approved” co-morbidities reported by AHCA.
